Home

Manchmal Leber Kiefer overall response rate Shinkan Leckage Lebensraum

Metastatic NSCLC Treatment Efficacy | LUMAKRAS™ (sotorasib)
Metastatic NSCLC Treatment Efficacy | LUMAKRAS™ (sotorasib)

BRAFTOVI + cetuximab | Overall Response Rate | ORR | BEACON CRC
BRAFTOVI + cetuximab | Overall Response Rate | ORR | BEACON CRC

Forest plot of the comparison of overall response rate (ORR).
Forest plot of the comparison of overall response rate (ORR).

Sirtex - Objective Response Rate
Sirtex - Objective Response Rate

Objective response rate assessment in oncology: Current situation and  future expectations
Objective response rate assessment in oncology: Current situation and future expectations

Best Overall Response Rate (full analysis population) | Download Table
Best Overall Response Rate (full analysis population) | Download Table

ORR (Objective Response Rate) and related statistics – Part 1
ORR (Objective Response Rate) and related statistics – Part 1

Objective response rate is a possible surrogate endpoint for survival in  patients with advanced, recurrent ovarian cancer - Gynecologic Oncology
Objective response rate is a possible surrogate endpoint for survival in patients with advanced, recurrent ovarian cancer - Gynecologic Oncology

PLOS ONE: Positive plasma cotinine during platinum-based chemotherapy is  associated with poor response rate in advanced non-small cell lung cancer  patients
PLOS ONE: Positive plasma cotinine during platinum-based chemotherapy is associated with poor response rate in advanced non-small cell lung cancer patients

ORR (Objective Response Rate) and related statistics – Part 1
ORR (Objective Response Rate) and related statistics – Part 1

ORR - "Overall Response Rate" by AcronymsAndSlang.com
ORR - "Overall Response Rate" by AcronymsAndSlang.com

Efficacy data | BENDEKA® (bendamustine HCl) injection
Efficacy data | BENDEKA® (bendamustine HCl) injection

Overall response rate | Download Table
Overall response rate | Download Table

Efficacy Data: Overall Response Rate | VITRAKVI® (larotrectinib)
Efficacy Data: Overall Response Rate | VITRAKVI® (larotrectinib)

Efficacy - Overall Response Rate | Aliqopa US HCP
Efficacy - Overall Response Rate | Aliqopa US HCP

ORR - Objective Response Rate
ORR - Objective Response Rate

Table 2 from Mucinous histology predicts for poor response rate and overall  survival of patients with colorectal cancer and treated with first-line  oxaliplatin- and/or irinotecan-based chemotherapy | Semantic Scholar
Table 2 from Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy | Semantic Scholar

Response rates Overall response rate and depth of response according to...  | Download Scientific Diagram
Response rates Overall response rate and depth of response according to... | Download Scientific Diagram

Durable Response Rate
Durable Response Rate

RECIST Tumor Response Results | TURALIO® (pexidartinib)
RECIST Tumor Response Results | TURALIO® (pexidartinib)

Tumor Response Rates | Advanced NSCLC | ABRAXANE (paclitaxel protein-bound  particles for injectable suspension) (albuminbound)
Tumor Response Rates | Advanced NSCLC | ABRAXANE (paclitaxel protein-bound particles for injectable suspension) (albuminbound)

RESONATE - Overall Response Rate | IMBRUVICA®
RESONATE - Overall Response Rate | IMBRUVICA®

Overall Response Rate of 76% in Advanced Melanoma Patients with Dynavax's  SD-101 in Combination with KEYTRUDA® (pembrolizumab); Data Presented Today  at the 2019 ASCO Annual Meeting | Dynavax Technologies Corporation
Overall Response Rate of 76% in Advanced Melanoma Patients with Dynavax's SD-101 in Combination with KEYTRUDA® (pembrolizumab); Data Presented Today at the 2019 ASCO Annual Meeting | Dynavax Technologies Corporation

The overall response rate | Download Table
The overall response rate | Download Table

PDF] Objective response rate assessment in oncology: Current situation and  future expectations | Semantic Scholar
PDF] Objective response rate assessment in oncology: Current situation and future expectations | Semantic Scholar

RECIST Tumor Response Results | TURALIO® (pexidartinib)
RECIST Tumor Response Results | TURALIO® (pexidartinib)